Jump to content

2,5-Dimethoxy-4-acetylamphetamine

From Wikipedia, the free encyclopedia
DOAc
Clinical data
Other names2,5-Dimethoxy-4-acetylamphetamine; 4-Acetyl-2,5-dimethoxyamphetamine; DOAc; DOAC
Drug classSerotonin 5-HT2 receptor modulator
Identifiers
  • 1-[4-(2-aminopropyl)-2,5-dimethoxyphenyl]ethanone
PubChem CID
ChemSpider
Chemical and physical data
FormulaC13H19NO3
Molar mass237.299 g·mol−1
3D model (JSmol)
  • CC(CC1=CC(=C(C=C1OC)C(=O)C)OC)N
  • InChI=1S/C13H19NO3/c1-8(14)5-10-6-13(17-4)11(9(2)15)7-12(10)16-3/h6-8H,5,14H2,1-4H3
  • Key:NWWLLPGDGZOZAT-UHFFFAOYSA-N

2,5-Dimethoxy-4-acetylamphetamine (DOAc) is a serotonin 5-HT2 receptor modulator of the amphetamine and DOx families.[1] Its affinities (Ki) for the human serotonin 5-HT2 receptors are 80.5 nM for the serotonin 5-HT2A receptor, 313 nM for the serotonin 5-HT2B receptor, and 91.3 nM for the serotonin 5-HT2C receptor.[1] These affinities are much lower than those of many other DOx derivatives, such as DOB, but are very similar to those of 3,4,5-trimethoxyamphetamine (TMA).[1]

References

[edit]
  1. ^ a b c Nelson DL, Lucaites VL, Wainscott DB, Glennon RA (January 1999). "Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors". Naunyn Schmiedebergs Arch Pharmacol. 359 (1): 1–6. doi:10.1007/pl00005315. PMID 9933142.
[edit]